We have been informed today by AMSL, who are the Australian distributors for Alutek and Alxoid immunotherapy injections, to expect up to a 2-3 week delay on any immunotherapy orders. This is due to the current impact of COVID on staffing and thus distribution. If you have only half a vial left, we would recommend[…]
There have been a number of enquiries from parents as to whether children with asthma, eczema, hayfever, and/or food/insect allergies can have the mRNA COVID vaccines (Pfizer for children 5 years+; Moderna for children 12 years+). The Australasian Society of Allergy and Immunology have a great question and answer web-link to address concerns parents may[…]
Some parents have been concerned whether they should continue their allergy shots (i.e allergen immunotherapy for hayfever and/or asthma) during the COVID-19 pandemic. Below is some information that may help, but remember it is very important speak to your Allergist if your are concerned. Will the immunotherapy shots increase my child’s chance of developing COVID-19?[…]
Due to the COVID-19 pandemic, pharmacies can deliver medicines prescribed by your doctor to your home to those with/suspected COVID-19 or vulnerable individuals. This is called the Home Medicine Service, and commenced on the 16th of March 202. It will be available only for 6 months. Who is this available to? This is only available[…]
Influenza vaccines are now available, and I encourage everyone to get their shot, particularly in the current climate. Influenza is very contagious, with the peak number of cases in Australia usually occurring between July to September (see the graph below). Influenza can be particularly serious for babies, pregnant women, the elderly and those with chronic[…]
Our findings on the mechanism underpinning acute FPIES reactions was published today in the Journal of Allergy and Clinical Immunology (https://www.jacionline.org/article/S0091-6749(19)30605-0/abstract). We found in children having an acute FPIES reaction, there was activation of the innate immune system (this is the part of the immune system normally provides us with rapid defense against pathogens; but[…]
We recently published a study on FPIES in the Journal of Allergy and Clinical Immunology in Practice (https://www.jaci-inpractice.org/article/S2213-2198(18)30677-9/abstract). This was conducted at the Children’s Hospital Westmead, Sydney, and we compared the clinical and laboratory features of FPIES with two conditions it is frequently misdiagnosed as – sepsis and gastroenteritis. The main findings were infants with[…]
The management of anaphylaxis is intramuscular adrenaline. The dose required for anaphylaxis is calculated based on the formula = 0.01 mL or mg of a 1:1000 dilution of adrenaline per kg of the patient (maximum dose = 0.5 mg = 500 mcg). Adrenaline auto-injectors allow for the management of anaphylaxis in community settings, and the[…]